Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redispersible nanoalum-adjuvanted hepatitis B vaccine microneedles with enhanced immunogenicity.

Drug delivery and translational research·2026
Same author

On-site loading of powder-attached microneedles enables quantitative and reproducible intradermal vaccine delivery.

International journal of pharmaceutics·2026
Same author

Emerging synthetic biology-assisted technologies for overcoming antibiotic resistance: CRISPR-Cas, bacteriophage, microbiome, and metabolic engineering-based solutions.

Journal of microbiology (Seoul, Korea)·2026
Same author

Prion Protein-Derived Cell-Penetrating Peptide Inhibits Type II Diabetes-Associated Islet Amyloid Polypeptide Aggregation and Cytotoxicity.

Biochemistry·2026
Same author

Spinal morphology-based multimodal AI for predicting pulmonary dysfunction in adolescent idiopathic scoliosis.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

Bst2-targeted senotherapy restores visual function by eliminating senescent retinal cells.

Nature communications·2026
Same journal

Economic and epidemiological burden of HPV-related diseases in the Czech Republic: A claims database analysis.

Human vaccines & immunotherapeutics·2026
Same journal

Shared clinical decision-making for vaccination: A view through the lens of mid-adult HPV vaccination.

Human vaccines & immunotherapeutics·2026
Same journal

Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.

Human vaccines & immunotherapeutics·2026
Same journal

Development of a theory-based provider-focused training to improve HPV vaccine recommendations for young adults.

Human vaccines & immunotherapeutics·2026
Same journal

Elranatamab: A novel B-cell maturation T-cell engager.

Human vaccines & immunotherapeutics·2026
Same journal

Mumps resurgence despite MMR: Limitations of current vaccines and the need for new strategies.

Human vaccines & immunotherapeutics·2026
See all related articles

Related Experiment Video

Updated: Dec 14, 2025

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

3.2K

Progress in microneedle array patch (MAP) for vaccine delivery.

Thuy Trang Nguyen1, Yujeong Oh2, Yunseo Kim2

  • 1Faculty of Pharmacy, Ho Chi Minh City University of Technology-HUTECH , Ho Chi Minh, Vietnam.

Human Vaccines & Immunotherapeutics
|July 16, 2020
PubMed
Summary
This summary is machine-generated.

Microneedle array patches (MAPs) offer a promising new method for vaccine delivery, demonstrating improved stability, safety, and efficacy in trials. Further development is ongoing to address cost, regulation, and optimal administration for widespread adoption.

Keywords:
developmentmicroneedlesstatusvaccine

More Related Videos

Polymeric Microneedle Array Fabrication by Photolithography
08:15

Polymeric Microneedle Array Fabrication by Photolithography

Published on: November 17, 2015

12.7K
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
08:19

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing

Published on: June 1, 2012

14.8K

Related Experiment Videos

Last Updated: Dec 14, 2025

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

3.2K
Polymeric Microneedle Array Fabrication by Photolithography
08:15

Polymeric Microneedle Array Fabrication by Photolithography

Published on: November 17, 2015

12.7K
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
08:19

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing

Published on: June 1, 2012

14.8K

Area of Science:

  • Biotechnology
  • Vaccinology
  • Drug Delivery Systems

Background:

  • Microneedle array patches (MAPs) are emerging as innovative platforms for vaccine administration.
  • Conventional vaccine delivery methods face challenges in stability, safety, and patient compliance.

Purpose of the Study:

  • To evaluate the potential of MAPs as a novel vaccine delivery system.
  • To assess the stability, safety, and immunological efficacy of vaccine MAPs compared to traditional methods.

Main Methods:

  • Review of preclinical and clinical trial data for vaccine MAPs.
  • Analysis of manufacturing capabilities for mass production of pharmaceutical and cosmetic MAPs.
  • Examination of regulatory discussions and efficacy/safety standards.

Main Results:

  • Vaccine MAPs demonstrated improved stability, safety, and immunological efficacy in preclinical and clinical studies.
  • Mass production systems for MAPs are adaptable for vaccine applications.
  • Clinical trials indicate comparable efficacy to conventional administration, with ongoing regulatory discussions.

Conclusions:

  • Vaccine MAPs present significant advantages including reduced pain, self-administration, enhanced stability, and convenience.
  • While challenges regarding cost, regulation, and FDA approval remain, MAP technology is advancing.
  • Vaccine MAPs are poised to complement, and potentially replace, traditional needle-and-syringe methods for certain vaccines in the future.